The aim of this review was to explore the status of urine sampling as a liquid biopsy for
noninvasive cancer research by reviewing used preanalytical parameters and protocols. We …

Precision medicine has transformed the way urothelial carcinoma is managed. However,
current practices are limited by the availability of tissue samples for genomic profiling and …

Glioma‐derived cell‐free DNA (cfDNA) is challenging to detect using liquid biopsy because
quantities in body fluids are low. We determined the glioma‐derived DNA fraction in …

Paper is the most abundant and inexpensive polymeric structure of cellulose available.
Paper has micro-porous capillary-like networks which are responsible for flow of solvents …

Colorectal cancer (CRC) is the second leading cause for cancer-related death globally.
Clinically, there is an urgent need for non-invasive CRC detection. This study assessed the …

Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …

Background The incidence of endometrial cancer is rising, and current diagnostics often
require invasive biopsy procedures. Urine may offer an alternative sample type, which is …

Simple Summary The use of biomarkers can provide information about the outcome of
cancer patients, the type of tumor, its malignant potential and the risk of recurrence, and may …

Bladder cancer is the 10th most common cancer type worldwide. Cystoscopy represents the
gold standard for bladder cancer diagnosis, but this procedure is invasive and painful …

Early detection of primary bladder cancer (BCa) is vital, because stage and grade have
been generally accepted not only as categorical but also as prognostic factors in patients …